Vanguard Group Inc Inozyme Pharma, Inc. Transaction History

Vanguard Group Inc

$5.37 Trillion
Q1 2025

A detailed history of Vanguard Group Inc transactions in Inozyme Pharma, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 2,758,478 shares of INZY stock, worth $11 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,758,478

Previous 2,633,249 4.76%

Holding current value

$11 Million

Previous $7.29 Million 65.59%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 09, 2025	BUY	$0.91 - $3.07 $113,958 - $384,453	125,229 Added 4.76%	2,758,478 $2.51 Million
Q4 2024 Feb 11, 2025	BUY	$2.48 - $5.54 $22,099 - $49,366	8,911 Added 0.34%	2,633,249 $7.29 Million
Q3 2024 Nov 13, 2024	SELL	$4.31 - $6.0 $21,425 - $29,826	-4,971 Reduced 0.19%	2,624,338 $13.7 Million
Q2 2024 Aug 13, 2024	BUY	$4.33 - $7.31 $910,551 - $1.54 Million	210,289 Added 8.69%	2,629,309 $11.7 Million
Q1 2024 May 10, 2024	BUY	$4.14 - $7.66 $140,751 - $260,424	33,998 Added 1.43%	2,419,020 $18.5 Million
Q4 2023 Feb 14, 2024	BUY	$2.71 - $4.5 $295,219 - $490,216	108,937 Added 4.79%	2,385,022 $10.2 Million
Q3 2023 Nov 14, 2023	BUY	$4.09 - $7.0 $3.6 Million - $6.16 Million	880,175 Added 63.05%	2,276,085 $9.56 Million
Q2 2023 Aug 14, 2023	BUY	$4.93 - $6.74 $333,366 - $455,758	67,620 Added 5.09%	1,395,910 $7.78 Million
Q1 2023 May 15, 2023	SELL	$1.3 - $5.73 $19,931 - $87,852	-15,332 Reduced 1.14%	1,328,290 $7.61 Million
Q4 2022 Feb 10, 2023	BUY	$1.05 - $2.82 $586 - $1,576	559 Added 0.04%	1,343,622 $1.41 Million
Q3 2022 Nov 14, 2022	SELL	$2.57 - $5.45 $28,663 - $60,783	-11,153 Reduced 0.82%	1,343,063 $3.6 Million
Q2 2022 Aug 12, 2022	BUY	$3.2 - $5.96 $2.77 Million - $5.15 Million	864,603 Added 176.59%	1,354,216 $6.46 Million
Q1 2022 May 13, 2022	BUY	$3.87 - $7.55 $3,459 - $6,749	894 Added 0.18%	489,613 $2 Million
Q4 2021 Feb 14, 2022	SELL	$5.58 - $11.5 $683,360 - $1.41 Million	-122,466 Reduced 20.04%	488,719 $3.33 Million
Q3 2021 Nov 12, 2021	BUY	$11.12 - $19.4 $3.07 Million - $5.35 Million	275,899 Added 82.29%	611,185 $7.08 Million
Q2 2021 Aug 13, 2021	BUY	$15.19 - $21.2 $5.09 Million - $7.11 Million	335,286 New	335,286 $5.71 Million

Others Institutions Holding INZY

# of Institutions

Shares Held

46M

Call Options Held

13.8K

Put Options Held

View Full List

About Inozyme Pharma, Inc.

Ticker INZY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,145,700
Market Cap $159M
Description
Inozyme Pharma, Inc., a rare disease biopharmaceutical company, engages in developing therapeutics for treating abnormal mineralization impacting the vasculature, soft tissue, and skeleton diseases. The company's lead product candidate is INZ-701, a soluble, recombinant protein to treat the rare genetic diseases of ENPP1 and ABCC6 deficiencies, ...

More about INZY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Inozyme Pharma, Inc. Transaction History